SHOCKING: Invo bioscience | Mind Blowing Facts

INVO Bioscience's Return On Capital Employed Overview

INVO Bioscience (NASDAQ:INVO) brought in sales totaling $162.60 thousand during Q1 according to data provided by Benzinga Pro. However, earnings decreased 2959.58%, resulting in a loss of $2.77 million.

Benzinga · Jun 22, 2022

12 Health Care Stocks Moving In Wednesday's Intraday Session

 

Benzinga · May 18, 2022

INVO Bioscience: Q1 Earnings Insights

INVO Bioscience (NASDAQ:INVO) reported its Q1 earnings results on Monday, May 16, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings INVO Bioscience beat estimated earnings by 8.0%, reporting an EPS of $-0.23 versus an estimate of $-0.25.

Benzinga · May 16, 2022